Key points are not available for this paper at this time.
Nowadays, hybrid drugs containing two or more covalently linked known potential pharmacophores are designed to simultaneously modulate multiple targets of multifactorial diseases to overcome the side effects associated with a single drug.
Abbot et al. (Sun,) studied this question.